The Complex Cancer Care Coverage Environment — What is the Role of Legislation? A Case Study from Massachusetts

FDA Approval and Regulation of Pharmaceuticals, 1983-2018

(2020) Jonathan J. Darrow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

(2019) Bishal Gyawali et al.   JAMA Internal Medicine

Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History

(2018) Amy J. Davidoff et al.   MEDICAL CARE

Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology

(2018) Bruno Kovic et al.   JAMA Internal Medicine

Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration

(2017) Huseyin Naci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Changes in Insurance Coverage and Stage at Diagnosis Among Nonelderly Patients With Cancer After the Affordable Care Act

(2017) Ahmedin Jemal et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer

(2016) Christopher S. Lathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011

(2015) Ya-Chen Tina Shih et al.   JOURNAL OF CLINICAL ONCOLOGY

Faster Drug Approvals Are Not Always Better and Can Be Worse

(2015) Rita F. Redberg   JAMA Internal Medicine

The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature

(2014) Christine M Bestvina et al.   Future Oncology

New FDA Breakthrough-Drug Category — Implications for Patients

(2014) Jonathan J. Darrow et al.   NEW ENGLAND JOURNAL OF MEDICINE